1.Pelliccia, A, Maron, BJ. Outer limits of the athlete's heart, the effect of gender, and relevance to the differential diagnosis with primary cardiac diseases. Cardiol Clin 1997; 15: 381–396.
2.Longhurst, JC, Kelly, AR, Gonyea, WJ, Mitchell, JH. Echocardiographic left ventricular masses in distance runners and weight lifters. J Appl Physiol 1980; 48: 154–162.
3.Dilaveris, PE, Gialafos, EJ, Sideris, SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998; 135: 733–738.
4.Dilaveris, PE, Gialafos, EJ, Andrikopoulos, GK, et al. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 2000; 23: 352–358.
5.Haskell, WL, Lee, IM, Pate, RR, et al. American College of Sports Medicine; American Heart Association: physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116: 1081–1093.
6.Friedman, HH. Diagnostic Electrocardiography and Vecterocardiography, New York: McGraw-Hill; 1971.
7.Pelliccia, A, Maron, BJ, Culasso, F, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000; 102: 278–284.
8.Pelliccia, A, Maron, BJ, Culasso, F, Spataro, A, Caselli, G. Ahlete's heart in women: echocardiographic characterization of highly trained elite female athletes. JAMA 1996; 276: 211–215.
9.Crouse, SF, Meade, T, Hansen, BE, Green, JS, Martin, SE. Electrocardiograms of collegiate football athletes. Clin Cardiol 2009; 32: 37–42.
10.Mont, L, Elosua, R, Brugada, J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace 2009; 11: 11–17.
11.Swanson, DR. Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism. Med Hypotheses 2006; 66: 1085–1092.
12.Pelliccia, A, Maron, BJ, Di Paolo, FM, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol 2005; 46: 690–696.
13.Mont, L, Tamborero, D, Elosua, R, et al. Investigators: physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace 2008; 10: 15–20.
14.Alessi, R, Nusynowitz, M, Abildskov, JA, Moe, GK. Nonuniform distribution of vagal effects on the atrial refractory period. Am J Physiol 1958; 194: 406–410.
15.Smith, ML, Hudson, DL, Graitzer, HM, Raven, PB. Exercise training bradycardia: the role of autonomic balance. Med Sci Sports Exerc 1989; 21: 40–44.
16.Svendenhag, J, Wallin, BG, Sundlöff, G, Henriksson, J. Skeletal muscle sympathetic activity at rest in trained and untrained subjects. Acta Physiol Scand 1984; 120: 499–504.
17.Loimaala, A, Huikuri, H, Oja, P, Pasanen, M, Vuori, I. Controlled 5-mo aerobic training improves heart rate but not heart rate variability or baroreflex sensitivity. J Appl Physiol 2000; 89: 1825–1829.
18.Buchheit, M, Simon, C, Piquard, F, Ehrhart, J, Brandenberger, G. Effects of increased training load on vagal-related indexes of heart rate variability: a novel sleep approach. Am J Physiol Heart Circ Physiol 2004; 287: H2813–H2818.
19.Puig, J, Freitas, J, Carvalho, MJ, et al. Spectral analysis of heart rate variability in athletes. J Sports Med Phys Fitness 1993; 33: 44–48.
20.Furlan, R, Piazza, S, Dell'Orto, S, et al. Early and late effects of exercise and athletic training on neural mechanisms controlling heart rate. Cardiovasc Res 1993; 27: 482–488.
21.Cousineau, D, Ferguson, RJ, de Champlain, J, Gauthier, P, Côté, P, Bourassa, M. Catecholamines in coronary sinus during exercise in man before and after training. J Appl Physiol 1977; 43: 801–806.
22.Manhem, P, Lecerof, H, Hökfelt, B. Plasma catecholamine levels in the coronary sinus, the left renal vein and peripheral vessels in healthy males at rest and during exercise. Acta Physiol Scand 1978; 104: 364–369.
23.Neri Serneri, GG, Boddi, M, Modesti, PA, et al. Increased cardiac sympathetic activity and insuline-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res 2001; 89: 977–982.
24.Esler, M. Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses. Pharmacol Toxicol 1993; 73: 243–253.
25.Iellamo, F, Legramante, JM, Pigozzi, F, et al. Conversion from vagal to sympathetic predominance with strenuous training in high-performance world class athletes. Circulation 2002; 105: 2719–2724.
26.Scholz, DG, Kitzman, DW, Hagen, PT, Ilstrup, DM, Edwards, WD. Age-related changes in normal human hearts during the first 10 decades of life. Part I (growth): a quantitative anatomic study of 200 specimens from subjects from birth to 19 years old. Mayo Clin Proc 1988; 63: 126–136.
27.Yildiz, M, Pazarli, P, Semiz, O, Kahyaoglu, O, Sakar, İ, Altinkaynak, S. Assessment of P wave dispersion on 12-lead electrocardiography in students who exercise regularly. Pacing Clin Electrophysiol 2008; 31: 580–583.
28.Pritchett, AM, Jacobsen, SJ, Mahoney, DW, Rodeheffer, RJ, Bailey, KR, Redfield, MM. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 2003; 4: 1036–1043.
29.Vaziri, SM, Larson, MG, Benjamin, EJ, Levy, D. Echocardiographic predictors of nonrheumatic atrial fibrillation: The Framingham Heart Study. Circulation 1994; 89: 724–730.